Seeking Alpha

Credit Suisse's Catherine Arnold cuts earnings forecasts for Merck (MRK -6.5%) but says she...

Credit Suisse's Catherine Arnold cuts earnings forecasts for Merck (MRK -6.5%) but says she would buy shares on the dip after the company revealed problems in clinical trials with a drug designed to prevent blood clots. Merck has other attractive drugs in its pipeline, she says, and integration of Schering-Plough will help it grow EPS at a pace faster than its peers.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|